← Back to Screener
Haemonetics Corporation (HAE)
Price$71.28
Value ScoreC
Growth ScoreC
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-20.30%
Price vs S&P 500 (4W)29.33%
VGM Score56.51
Market Capitalization$3.24B
P/E Ratio (Annual)33.29x
All Metrics
P/CF (Annual)11.05x
Book Value / Share (Quarterly)$17.60
P/TBV (Annual)7.32x
Revenue Growth (3Y)4.51%
Cash Flow / Share (Quarterly)$4.61
Price vs S&P 500 (YTD)-19.22%
Gross Margin (TTM)59.00%
Net Profit Margin (TTM)7.29%
EPS (TTM)$2.03
10-Day Avg Trading Volume0.94M
EPS Excl Extra (TTM)$2.03
Revenue Growth (5Y)8.91%
EPS (Annual)$2.05
ROI (Annual)4.82%
Gross Margin (Annual)59.00%
Net Profit Margin (5Y Avg)8.57%
Cash / Share (Quarterly)$5.42
P/E Basic Excl Extra (TTM)33.29x
Revenue Growth QoQ (YoY)4.76%
EPS Growth (5Y)5.81%
P/E Normalized (Annual)33.29x
ROA (Last FY)4.06%
Revenue Growth TTM (YoY)-1.97%
EBITD / Share (TTM)$4.24
ROE (5Y Avg)12.96%
Operating Margin (TTM)11.75%
Cash Flow / Share (Annual)$4.61
P/B Ratio4.07x
P/B Ratio (Quarterly)3.21x
Net Income / Employee (Annual)$32,200
EV / Revenue (TTM)3.16x
Net Interest Coverage (TTM)5.46x
ROA (TTM)3.98%
EPS Growth QoQ (YoY)28.61%
EV / EBITDA (TTM)21.02x
EPS Incl Extra (Annual)$2.05
Current Ratio (Annual)2.95x
Quick Ratio (Quarterly)1.64x
3-Month Avg Trading Volume0.86M
52-Week Price Return1.25%
EV / Free Cash Flow (Annual)20.23x
P/E Incl Extra (TTM)33.29x
Revenue / Employee (TTM)$441,300
Tangible BV / Share (Quarterly)$7.70
P/S Ratio (Annual)2.43x
Asset Turnover (Annual)0.56x
52-Week High$87.32
Operating Margin (5Y Avg)12.43%
EPS Excl Extra (Annual)$2.05
CapEx CAGR (5Y)18.01%
Tangible BV CAGR (5Y)-0.97%
26-Week Price Return-12.38%
Quick Ratio (Annual)1.64x
13-Week Price Return10.98%
Total Debt / Equity (Annual)1.54x
Current Ratio (Quarterly)2.95x
Enterprise Value$4.22B
Revenue / Share Growth (5Y)10.67%
Asset Turnover (TTM)0.55x
Book Value / Share Growth (5Y)4.13%
Revenue / Employee (Annual)$441,300
Inventory Turnover (Annual)1.63x
Pretax Margin (Annual)9.60%
Cash / Share (Annual)$5.42
3-Month Return Std Dev40.14%
Gross Margin (5Y Avg)55.09%
Net Income / Employee (TTM)$32,200
EBITDA CAGR (5Y)10.38%
EBITDA Interim CAGR (5Y)5.02%
ROE (Last FY)12.22%
Net Interest Coverage (Annual)5.46x
EPS Basic Excl Extra (Annual)$2.05
P/FCF (TTM)15.53x
Receivables Turnover (TTM)6.36x
EV / Free Cash Flow (TTM)20.23x
Total Debt / Equity (Quarterly)1.54x
EPS Incl Extra (TTM)$2.03
Receivables Turnover (Annual)6.36x
ROI (TTM)4.67%
P/S Ratio (TTM)2.43x
Pretax Margin (5Y Avg)11.06%
Revenue / Share (Annual)$28.17
Tangible BV / Share (Annual)$7.70
Forward P/E13.65x
Free OCF CAGR (5Y)23.77%
Price vs S&P 500 (52W)-23.12%
P/E Ratio (TTM)33.29x
EPS Growth TTM (YoY)-38.74%
Year-to-Date Return-11.07%
5-Day Price Return6.04%
EPS Normalized (Annual)$2.05
ROA (5Y Avg)4.91%
Net Profit Margin (Annual)7.29%
Month-to-Date Return5.12%
Cash Flow / Share (TTM)$4.33
EBITD / Share (Annual)$4.24
EPS Growth (3Y)-2.91%
Operating Margin (Annual)11.75%
LT Debt / Equity (Annual)1.53x
P/CF (TTM)11.05x
ROI (5Y Avg)5.96%
P/E Excl Extra (TTM)33.29x
LT Debt / Equity (Quarterly)1.53x
EPS Basic Excl Extra (TTM)$2.03
P/TBV (Quarterly)7.32x
P/B Ratio (Annual)3.21x
Inventory Turnover (TTM)1.63x
Pretax Margin (TTM)9.60%
Book Value / Share (Annual)$17.60
Price vs S&P 500 (13W)2.72%
Net Margin Growth (5Y)-4.40%
Beta0.54x
P/FCF (Annual)15.53x
Revenue / Share (TTM)$28.86
ROE (TTM)11.32%
52-Week Low$47.32
vGradeC
gGradeC
mGradeB
vgmGradeC
Show chart for
Earnings Surprise History
Q4 261.29est. 1.28
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.93
3.93
3.93
3.93
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HAEHaemonetics Corporation | C | C | B | $71.28 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Haemonetics provides medical solutions for blood and plasma collection, processing, and transfusion services across three business segments: plasma, blood center, and hospital. The plasma and hospital segments drive growth due to robust market potential, while the blood center segment faces competitive headwinds. Revenue is generated through sales of disposable collection and processing sets and supporting equipment.